Key facts
- This page summarizes David M. Rubenstein's Form 4 filing for Moderna, Inc. (MRNA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 May 2026, 17:36.
David M. Rubenstein - 30 Apr 2026 Form 4 Insider Report for Moderna, Inc. (MRNA)
- Reporting relationship
- Director
- Issuer ticker
- MRNA
- Reported as of
- 30 Apr 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 May 2026, 17:36:52 UTC
- Prior SEC filing
- 20 Mar 2026
- Next SEC filing
- 08 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ James Dillon, As Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David M. Rubenstein filed Form 4 for Moderna, Inc. (MRNA) on 04 May 2026.
Change
- Previous filing in this sequence was filed on 20 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001543895
Primary reporting owner
Rubenstein David M.
- Relationship
- Director
- Address
- C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE
- Signature
- /s/ James Dillon, As Attorney-in-Fact
- Signature date
- 04 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MRNA
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +8,116
- Change %
- +531%
- Price
- Shares after
- 9,643
- Date
- 30 Apr 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MRNA
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -8,116
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 30 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,116
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted stock units convert into common stock on a one-for-one basis.
Footnote F2
The shares subject to this restricted stock unit award vested in full on April 30, 2026.